{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T22:48:51Z","timestamp":1777762131822,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015990","name":"Sanofi Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K07182"],"award-info":[{"award-number":["18K07182"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K09310"],"award-info":[{"award-number":["20K09310"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21K07825"],"award-info":[{"award-number":["21K07825"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.thromres.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:17:12Z","timestamp":1679023032000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor"],"prefix":"10.1016","volume":"231","author":[{"given":"Akihisa","family":"Oda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kitabatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Ouji-sageshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Sonobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Goitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2023.03.003_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.thromres.2023.03.003_bb0010","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1056\/NEJMoa1511769","article-title":"Factor VIII-mimetic function of humanized bispecific antibody in hemophilia A","volume":"374","author":"Shima","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2023.03.003_bb0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bjh.16574","article-title":"Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia a patients with inhibitors","volume":"190","author":"Furukawa","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.003_bb0020","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2007-11-123844","article-title":"The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells","volume":"111","author":"Mamani-Matsuda","year":"2008","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.thromres.2023.03.003_bb0025","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","article-title":"Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A","volume":"130","author":"Zerra","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2023.03.003_bb0030","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary Allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"Navarrete","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"20","key":"10.1016\/j.thromres.2023.03.003_bb0035","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia a mice","volume":"3","author":"Jing","year":"2019","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.thromres.2023.03.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159925","article-title":"Immune tolerance against infused FVIII in hemophilia a is mediated by PD-L1+ tregs","volume":"132","author":"Becker-Gotot","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.thromres.2023.03.003_bb0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-0037-1613094","article-title":"Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII","volume":"87","author":"Hausl","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"33","key":"10.1016\/j.thromres.2023.03.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12920","article-title":"Putative role of marginal zone B cells in pathophysiological processes","volume":"92","author":"Marinkovic","year":"2020","journal-title":"Scand. J. Immunol."},{"issue":"8","key":"10.1016\/j.thromres.2023.03.003_bb0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.003_bb0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4049\/jimmunol.1700461","article-title":"Here, there, and anywhere? Arguments for and against the physical plasma cell survival niche","volume":"199","author":"Wilmore","year":"2017","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.thromres.2023.03.003_bb0070","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/dvg.22829","article-title":"Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen development","volume":"52","author":"Nakahara","year":"2014","journal-title":"Genesis"},{"issue":"6","key":"10.1016\/j.thromres.2023.03.003_bb0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s12185-021-03108-8","article-title":"Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia a patients with inhibitor","volume":"113","author":"Nakajima","year":"2021","journal-title":"Int. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.03.003_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17474086.2019.1604213","article-title":"An update on the 'danger theory' in inhibitor development in hemophilia A","volume":"12","author":"Schep","year":"2019","journal-title":"Expert. Rev. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2023.03.003_bb0085","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/hae.13852","article-title":"Individual combinations of danger signals synergistically increase FVIII product immunogenicity","volume":"25","author":"Miller","year":"2019","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2023.03.003_bb0090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2516.2009.02122.x","article-title":"New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development","volume":"16","author":"Kurnik","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2023.03.003_bb0095","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/s-0038-1637734","article-title":"Human dendritic cells synergistically activated by FVIII plus LPS induce activation of autologous CD4+ T cells","volume":"118","author":"Miller","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.03.003_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1756-8722-6-61","article-title":"An evolving new paradigm: endothelial cells\u2013conditional innate immune cells","volume":"6","author":"Mai","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.003_bb0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.thromres.2023.03.003_bb0110","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1182\/blood-2011-08-374645","article-title":"CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice","volume":"119","author":"Steinitz","year":"2012","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.thromres.2023.03.003_bb0115","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1073\/pnas.1606751113","article-title":"Biomechanics of red blood cells in human spleen and consequences for physiology and disease","volume":"113","author":"Pivkin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.thromres.2023.03.003_bb0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.it.2011.09.001","article-title":"Staying alive: regulation of plasma cell survival","volume":"32","author":"Tangye","year":"2011","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.thromres.2023.03.003_bb0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","article-title":"Cellular niches controlling B lymphocyte behavior within bone marrow during development","volume":"20","author":"Tokoyoda","year":"2004","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.thromres.2023.03.003_bb0130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.14236","article-title":"Impact of CXCR4\/CXCL12 blockade on Normal plasma cells in vivo","volume":"17","author":"Moore","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.003_bb0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.thromres.2023.03.003_bb0140","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.03.003_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2016.01.005","article-title":"Strategies to target long-lived plasma cells for treating hemophilia a inhibitors","volume":"301","author":"Liu","year":"2016","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.003_bb0150","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1038\/s41598-018-26693-x","article-title":"Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1","volume":"8","author":"Oda","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.003_bb0155","doi-asserted-by":"crossref","first-page":"20408","DOI":"10.1038\/s41598-019-56984-w","article-title":"Transcription factor Tlx1 marks a subset of lymphoid tissue organizer-like mesenchymal progenitor cells in the neonatal spleen","volume":"9","author":"Ueno","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.003_bb0160","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.122.4.1421","article-title":"Synergy between T cell-replacing factor and bacterial lipopolysaccharides (LPS) in the primary antibody response in vitro: a model for lipopolysaccharide adjuvant action","volume":"122","author":"Jacobs","year":"1979","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.003_bb0165","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm914","article-title":"Bone marrow as a priming site for T-cell responses to blood-borne antigen","volume":"9","author":"Feuerer","year":"2003","journal-title":"Nat. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:25:52Z","timestamp":1777472752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"alternative-id":["S0049384823000774"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.003","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}